3 Hospitals Chain, Ice Cream Maker and Valves Maker Stocks With a Strong Future Roadmap: Fortis Healthcare, Vadilal Industries and Jash Engineering
- November 18, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
Fortis Healthcare, Vadilal Industries and Jash Engineering: ROE of 10.5% to 18.2% and FY22 to FY26 revenue CAGR of 12.4% to 21.2%. Prices as of 17 Nov 2026.
Quick Answer
The three hospital, ice cream and valve stocks to watch are Fortis Healthcare, Vadilal Industries and Jash Engineering. Their return on equity ranges from 10.5% to 18.2%, and their revenue compound annual growth from FY22 to FY26 ranges from 12.4% to 21.2%. Vadilal Industries leads on both return on equity at 18.2% and revenue growth at 21.2% a year. Prices are based on the 17 November 2026 close, and this article is educational, not investment advice.
Hospital, ice cream and valve stocks bring together companies with a visible plan for the years ahead. Fortis Healthcare, Vadilal Industries and Jash Engineering cover a hospitals chain, an ice cream maker and a valves maker.
This list covers three hospital, ice cream and valve stocks with complete current figures: Fortis Healthcare, Vadilal Industries and Jash Engineering. Every figure comes from the latest reported financials and the 17 November 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Hospital, Ice Cream and Valve Stocks?
Hospital, ice cream and valve stocks are listed companies that run multi-speciality hospitals and diagnostic centres, make ice cream and frozen foods for homes and outlets, and make valves and flow control equipment for water and sewage projects. Their earnings depend on patient numbers, dessert demand and water project spending.
Hospital, Ice Cream and Valve Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| Fortis Healthcare | 806.8 | 55,554 | 51.9 | 59.6 | 10.5 | 0.35 |
| Vadilal Industries | 6,879.5 | 5,137 | 23.4 | 33.9 | 18.2 | 0.27 |
| Jash Engineering | 558.7 | 3,380 | 39.4 | 44.4 | 14.7 | 0.20 |
On valuation, all three trade at a P/E below their industry P/E, which means the market is pricing them at a lower multiple than their peer group. Readers comparing hospital, ice cream and valve stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in hospital, ice cream and valve stocks can use the coming numbers to test whether growth is holding.
Why Do Hospital, Ice Cream and Valve Stocks Have a Strong Roadmap in India?
Hospital, ice cream and valve stocks have a strong roadmap in India because wider access to quality hospital care, rising demand for frozen desserts and large water supply projects keep widening the market for these companies.
- Hospitals. Patients look for specialist treatment.
- Ice cream. Families buy more frozen treats.
- Valves. City water projects need flow control.
Why Fortis Healthcare Features Among These Hospital, Ice Cream and Valve Stocks
Among the hospital, ice cream and valve stocks on this list, Fortis Healthcare operates a network of multi-specialty hospitals across India, with strengths in cardiac sciences, oncology, neurosciences and orthopaedics, and it also runs a diagnostics business.
The company has a return on equity of 10.5%, a debt to equity ratio of 0.35 and a market capitalisation of Rs 55,554 crore. The stock trades at a P/E of 51.9, below the industry P/E of 59.6.
Revenue rose from Rs 5,745 crore in FY22 to Rs 9,178 crore in FY26, a compound annual growth rate of 12.4%. Net profit grew from Rs 790 crore in FY22 to Rs 1,064 crore in FY26, which works out to a compound annual growth rate of 7.7%. In the June 2026 quarter, revenue grew 17.3% year on year to Rs 2,560 crore, while net profit rose 2.3% to Rs 273 crore.
Roadmap: The company is adding beds at existing hospitals and building new capacity in cities where demand for advanced care is rising. Its diagnostics arm and a growing share of complex procedures widen the earnings base beyond routine admissions.
What to watch: Track bed additions, occupancy and revenue per occupied bed.
Why Vadilal Industries Features Among These Hospital, Ice Cream and Valve Stocks
Among the multi-speciality care, frozen dessert and flow control shares on this list, Vadilal Industries, based in Ahmedabad, makes ice creams and frozen desserts and also has processed foods and a franchise-led network of parlours.
Revenue rose from Rs 706 crore in FY22 to Rs 1,525 crore in FY26, a compound annual growth rate of 21.2%. Net profit grew from Rs 44.7 crore in FY22 to Rs 155 crore in FY26, which works out to a compound annual growth rate of 36.5%.
In the June 2026 quarter, revenue grew 38.6% year on year to Rs 707 crore, while net profit rose 95.4% to Rs 131 crore. The company has a return on equity of 18.2%, a debt to equity ratio of 0.27 and a market capitalisation of Rs 5,137 crore. The stock trades at a P/E of 23.4, below the industry P/E of 33.9.
Roadmap: Rising ice cream consumption, deeper cold-chain distribution and new flavours and formats support revenue. The company is widening its retail footprint and gaining share in organised frozen desserts.
What to watch: Follow seasonal demand and the pace of new distribution tie-ups.
Why Jash Engineering Features Among These Hospital, Ice Cream and Valve Stocks
Among the three companies on this list, Jash Engineering makes flow control products such as sluice gates, valves, penstocks and screens for water and wastewater projects, and serves irrigation, power and industrial customers.
In the June 2026 quarter, revenue grew 17.3% year on year to Rs 156 crore. Revenue rose from Rs 374 crore in FY22 to Rs 757 crore in FY26, a compound annual growth rate of 19.3%.
Net profit grew from Rs 32.2 crore in FY22 to Rs 75.5 crore in FY26, which works out to a compound annual growth rate of 23.8%. The company has a return on equity of 14.7%, a debt to equity ratio of 0.20 and a market capitalisation of Rs 3,380 crore. The stock trades at a P/E of 39.4, below the industry P/E of 44.4.
Roadmap: Spending on water supply, sewage treatment and irrigation projects creates a steady stream of orders for flow control equipment. The company has widened its range through acquisitions and sells to customers in India and overseas.
What to watch: Track order inflow from water projects and the margin trend as new product lines scale.
Fortis Healthcare vs Vadilal Industries vs Jash Engineering on Key Financials
The table below sets the three hospital, ice cream and valve stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| Fortis Healthcare | 5,745 | 9,178 | 12.4% | 1,064 | 11.6% |
| Vadilal Industries | 706 | 1,525 | 21.2% | 155 | 10.2% |
| Jash Engineering | 374 | 757 | 19.3% | 75.5 | 10.0% |
Vadilal Industries posts the highest return on equity in this group at 18.2%. Fortis Healthcare has the largest FY26 revenue at Rs 9,178 crore, and Vadilal Industries shows the fastest revenue growth with a 21.2% compound annual rate. A useful habit with hospital, ice cream and valve stocks is to check each new quarterly result against the capacity plans the company described earlier.
The June 2026 quarter, the latest reported, gives a fresh read on momentum:
| Company | Q1 FY26 Revenue (Rs Cr) | Q1 FY27 Revenue (Rs Cr) | Year-on-Year Growth |
|---|---|---|---|
| Fortis Healthcare | 2,182 | 2,560 | 17.3% |
| Vadilal Industries | 510 | 707 | 38.6% |
| Jash Engineering | 133 | 156 | 17.3% |
Key Risks to Check Before Investing in Hospital, Ice Cream and Valve Stocks
Every theme carries risks that deserve a check before any decision. For these hospital, ice cream and valve stocks, the main points are: Long-term multi-speciality care, frozen dessert and flow control shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Capacity ramp up. New hospitals take time to fill beds and reach full returns.
- Consumer spending. Sales follow festivals, incomes and consumer mood.
- Government spending. Public project funding can shift between periods.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter hospital, ice cream and valve stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Hospital, Ice Cream and Valve Stocks
Hospital, ice cream and valve stocks suit investors who prefer to study business strength before price moves. Fortis Healthcare, Vadilal Industries and Jash Engineering each have a clear plan to grow. Based on the 17 November 2026 close, Fortis Healthcare trades at Rs 806.8, Vadilal Industries at Rs 6,879.5 and Jash Engineering at Rs 558.7. Valuation matters as much as growth, so compare each company’s P/E with its industry P/E before adding any of these hospital, ice cream and valve stocks to a watchlist.
Download the Univest iOS App or Univest Android App to track hospital, ice cream and valve stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are hospital, ice cream and valve stocks?
Ans. Hospital, ice cream and valve stocks are listed companies that run multi-speciality hospitals and diagnostic centres, make ice cream and frozen foods for homes and outlets, and make valves and flow control equipment for water and sewage projects. Their earnings depend on patient numbers, dessert demand and water project spending. This list looks at three of them, Fortis Healthcare, Vadilal Industries and Jash Engineering, using reported FY22 to FY26 financials and the 17 November 2026 closing prices.
Which hospital, ice cream and valve stocks are covered in this list?
Ans. This list covers Fortis Healthcare, Vadilal Industries and Jash Engineering. Based on the 17 November 2026 close, Fortis Healthcare traded at Rs 806.8, Vadilal Industries at Rs 6,879.5 and Jash Engineering at Rs 558.7. Their return on equity ranges from 10.5% to 18.2%, and their revenue compound annual growth from FY22 to FY26 ranges from 12.4% to 21.2%.
Why do hospital, ice cream and valve stocks have a strong future roadmap in India?
Ans. Hospital, ice cream and valve stocks have a strong roadmap in India because wider access to quality hospital care, rising demand for frozen desserts and large water supply projects keep widening the market for these companies. The main drivers are as follows. Hospitals. Patients look for specialist treatment. Ice cream. Families buy more frozen treats. Valves. City water projects need flow control. Together these factors give the companies on this list a visible path for growth over the coming years.
How has Fortis Healthcare performed financially?
Ans. Revenue rose from Rs 5,745 crore in FY22 to Rs 9,178 crore in FY26, a compound annual growth rate of 12.4%. Net profit grew from Rs 790 crore in FY22 to Rs 1,064 crore in FY26, which works out to a compound annual growth rate of 7.7%. In the June 2026 quarter, revenue grew 17.3% year on year to Rs 2,560 crore, while net profit rose 2.3% to Rs 273 crore. The company has a return on equity of 10.5%, a debt to equity ratio of 0.35 and a market capitalisation of Rs 55,554 crore. The stock trades at a P/E of 51.9, below the industry P/E of 59.6. Looking ahead, the company is adding beds at existing hospitals and building new capacity in cities where demand for advanced care is rising. Its diagnostics arm and a growing share of complex procedures widen the earnings base beyond routine admissions.
How has Vadilal Industries performed financially?
Ans. Revenue rose from Rs 706 crore in FY22 to Rs 1,525 crore in FY26, a compound annual growth rate of 21.2%. Net profit grew from Rs 44.7 crore in FY22 to Rs 155 crore in FY26, which works out to a compound annual growth rate of 36.5%. In the June 2026 quarter, revenue grew 38.6% year on year to Rs 707 crore, while net profit rose 95.4% to Rs 131 crore. The company has a return on equity of 18.2%, a debt to equity ratio of 0.27 and a market capitalisation of Rs 5,137 crore. The stock trades at a P/E of 23.4, below the industry P/E of 33.9. Looking ahead, rising ice cream consumption, deeper cold-chain distribution and new flavours and formats support revenue. The company is widening its retail footprint and gaining share in organised frozen desserts.
How has Jash Engineering performed financially?
Ans. Revenue rose from Rs 374 crore in FY22 to Rs 757 crore in FY26, a compound annual growth rate of 19.3%. Net profit grew from Rs 32.2 crore in FY22 to Rs 75.5 crore in FY26, which works out to a compound annual growth rate of 23.8%. In the June 2026 quarter, revenue grew 17.3% year on year to Rs 156 crore. The company has a return on equity of 14.7%, a debt to equity ratio of 0.20 and a market capitalisation of Rs 3,380 crore. The stock trades at a P/E of 39.4, below the industry P/E of 44.4. Looking ahead, spending on water supply, sewage treatment and irrigation projects creates a steady stream of orders for flow control equipment. The company has widened its range through acquisitions and sells to customers in India and overseas.
What risks should investors check before buying hospital, ice cream and valve stocks?
Ans. Investors should check a few risks before buying hospital, ice cream and valve stocks. Capacity ramp up. New hospitals take time to fill beds and reach full returns. Consumer spending. Sales follow festivals, incomes and consumer mood. Government spending. Public project funding can shift between periods. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of hospital, ice cream and valve stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 17 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.